Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarker time out.
Petzold A, Bowser R, Calabresi P, Zetterberg H, Uitdehaag BM. Petzold A, et al. Among authors: bowser r. Mult Scler. 2014 Oct;20(12):1560-3. doi: 10.1177/1352458514524999. Epub 2014 Feb 20. Mult Scler. 2014. PMID: 24557857 Review.
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.
Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, Lehnert S, Malaspina A, Parnetti L, Petzold A, Shaw P, Sherman A, Steinacker P, Süssmuth S, Teunissen C, Tumani H, Wuolikainen A, Ludolph A; Volcano Group. Otto M, et al. Among authors: bowser r. Amyotroph Lateral Scler. 2012 Jan;13(1):1-10. doi: 10.3109/17482968.2011.627589. Amyotroph Lateral Scler. 2012. PMID: 22214350 Free article. Review.
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Mattsson N, Zegers I, Andreasson U, Bjerke M, Blankenstein MA, Bowser R, Carrillo MC, Gobom J, Heath T, Jenkins R, Jeromin A, Kaplow J, Kidd D, Laterza OF, Lockhart A, Lunn MP, Martone RL, Mills K, Pannee J, Ratcliffe M, Shaw LM, Simon AJ, Soares H, Teunissen CE, Verbeek MM, Umek RM, Vanderstichele H, Zetterberg H, Blennow K, Portelius E. Mattsson N, et al. Among authors: bowser r. Biomark Med. 2012 Aug;6(4):409-17. doi: 10.2217/bmm.12.39. Biomark Med. 2012. PMID: 22917143 Review.
pNfH is a promising biomarker for ALS.
Ganesalingam J, An J, Bowser R, Andersen PM, Shaw CE. Ganesalingam J, et al. Among authors: bowser r. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Mar;14(2):146-9. doi: 10.3109/21678421.2012.729596. Epub 2012 Oct 22. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23134506
A multi-center study of neurofilament assay reliability and inter-laboratory variability.
Gray E, Oeckl P, Amador MDM, Andreasson U, An J, Blennow K, Bowser R, De Schaepdryver M, Heslegrave A, Kuhle J, Maceski A, Koel-Simmelink M, Lamari F, Lombardi V, Malaspina A, Nilsson I, Poesen K, Salachas F, Steinacker P, Teunissen CE, Van Damme P, Zetterberg H, Ludolph A, Jeromin A, Turner MR, Otto M. Gray E, et al. Among authors: bowser r. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Aug;21(5-6):452-458. doi: 10.1080/21678421.2020.1779300. Epub 2020 Jun 19. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 32558597
Use of biomarkers in ALS drug development and clinical trials.
Bakkar N, Boehringer A, Bowser R. Bakkar N, et al. Among authors: bowser r. Brain Res. 2015 May 14;1607:94-107. doi: 10.1016/j.brainres.2014.10.031. Epub 2014 Oct 24. Brain Res. 2015. PMID: 25452025 Free PMC article. Review.
Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
Vu LT, Bowser R. Vu LT, et al. Among authors: bowser r. Neurotherapeutics. 2017 Jan;14(1):119-134. doi: 10.1007/s13311-016-0503-x. Neurotherapeutics. 2017. PMID: 27933485 Free PMC article. Review.
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium; Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium; Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium; Gitler AD, Harris T, Myers RM; NYGC ALS Consortium; Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation; Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium; Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium; Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium; Corcia P, Laaks… See abstract for full author list ➔ Nicolas A, et al. Among authors: bowser r. Neuron. 2018 Mar 21;97(6):1267-1288. doi: 10.1016/j.neuron.2018.02.027. Neuron. 2018. PMID: 29566793 Free PMC article.
236 results